Search Result - Primary Antibodies

  • anti-CD11a / LFA1 alpha antibody [MEM-25]
  • Cat. No: ARG62707  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, IP, FuncSt
  • Specificity: The clone MEM-25 reacts with CD11a (alpha subunit of human LFA-1), a 170-180 kDa type I transmembrane glycoprotein expressed on B and T lymphocytes, monocytes, macrophages, neutrophils, basophils and eosinophils.
    HLDA IV; WS Code NL 209
  • Conjugation: Un-conjugated
  • anti-CD11a / LFA1 alpha antibody [MEM-83]
  • Cat. No: ARG62708  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, IP, FuncSt
  • Specificity: The clone MEM-83 reacts with CD11a (alpha subunit of human LFA-1), a 170-180 kDa type I transmembrane glycoprotein expressed on B and T lymphocytes, monocytes, macrophages, neutrophils, basophils and eosinophils.
    HLDA IV; WS Code N 211
  • Conjugation: Un-conjugated
  • anti-CD14 antibody [B-A8]
  • Cat. No: ARG62727  (Mouse mAb)
  • Reactivity: Hu
  • Application: ELISA, FACS, ICC/IF, IHC-P
  • Specificity: The clone B-A8 reacts with CD14, a 53-55 kDa GPI (glycosylphosphatidylinositol)-linked membrane glycoprotein expressed on monocytes, macrophages and weakly on granulocytes; also expressed by most tissue macrophages.
  • Conjugation: Un-conjugated
  • anti-CD147 antibody [MEM-M6/1]
  • Cat. No: ARG62731  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, IHC-P, IP, WB
  • Specificity: The clone MEM-M6/1 recognizes an epitope in the N-terminal Ig domain (D1) of CD147 (Neurothelin), a 50-60 kDa type I transmembrane glycoprotein primarily expressed on all leukocytes, red blood cells, platelets and endothelial cells; it is not expressed by resting lymphocytes.
    MEM-M6/1 is a high-affinity antibody capable of binding to unstimulated peripheral blood T cells.
  • Conjugation: Un-conjugated
  • anti-CD16 antibody [MEM-154]
  • Cat. No: ARG62740  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, IP, WB, FuncSt
  • Specificity: The clone MEM-154 reacts with the epitope on CD16 antigen that residing in proximity to FG loop (probably BC or C'E loop). CD16 is a low affinity receptor for aggregated IgG (FcgammaRIII antigen). MEM-154 reacts with CD16+ granulocytes.
    HLDA V; WS Code M MA068
    HLDA V; WS Code NK NK51
  • Conjugation: Un-conjugated
  • anti-CD16 antibody [LNK16] (FITC)
  • Cat. No: ARG62744  (Mouse mAb)
  • Reactivity: Hu, NHuPrm
  • Application: FACS
  • Specificity: The clone LNK16 reacts with CD16, a low affinity receptor for aggregated IgG (FcgammaRIII antigen). CD16 exists in two different isoforms: CD16a (FcgammaRIIIA; 50-65 kDa; expressed on NK-cells, monocytes and macrophages) and CD16b (FcgammaRIIIB; 48 kDa; mainly expressed on neutrophils).
    HLDA V; WS Code M MA069
    HLDA V; WS Code NK NK50
  • Conjugation: FITC
  • anti-CD21 antibody [LT21] (FITC)
  • Cat. No: ARG62772  (Mouse mAb)
  • Reactivity: Hu, Dog, Pig, Bov
  • Application: FACS
  • Specificity: The clone LT21 reacts with CD21 (CR2), a 145 kDa transmembrane glycoprotein (complement C3d receptor - C3dR) expressed on B lymphocytes, follicular dendritic cells, some epithelial cells and a subsets of T lymphocytes. It is not expressed on immature B cells.
    HLDA VI; WS Code B CD21.1
  • Conjugation: FITC
  • anti-CD3 epsilon antibody [OKT3] (low endotoxin)
  • Cat. No: ARG62801  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, IHC-Fr, FuncSt
  • Specificity: The clone OKT3 recognizes the CD3 antigen of the TCR/CD3 complex on mature human T cells. This antibody, also known as Orthoclone OKT3 or Muromonab-CD3, has been extensively used as a drug for therapy of acute, glucocorticoid resistant rejection of allogenic renal, heart and liver transplants. It has also been investigated for use in treating T-cell acute lymphoblastic leukemia.
    HLDA VI; WS Code T6T-R3
  • Conjugation: Un-conjugated
  • anti-CD3 epsilon antibody [OKT3]
  • Cat. No: ARG62804  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, IHC-Fr, FuncSt
  • Specificity: The clone OKT3 recognizes the CD3 antigen of the TCR/CD3 complex on mature human T cells. This antibody, also known as Orthoclone OKT3 or Muromonab-CD3, has been extensively used as a drug for therapy of acute, glucocorticoid resistant rejection of allogenic renal, heart and liver transplants. It has also been investigated for use in treating T-cell acute lymphoblastic leukemia.
    HLDA VI; WS Code T6T-R3
  • Conjugation: Un-conjugated
  • anti-CD34 antibody [4H11(APG)]
  • Cat. No: ARG62820  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS, ICC/IF, IHC-P, WB
  • Specificity: The clone 4H11(APG) reacts with Class III epitope on CD34 (Mucosialin), a 110-115 kDa monomeric transmembrane phosphoglycoprotein expressed on hematopoietic progenitors cells and on the most pluripotential stem cells; it is gradually lost on progenitor cells. 4H11(APG) completely blocks binding of Class II antibody QBEnd10 and Class III antibodies BIRMA K3 and 8G12 on KG1a cell line.
    HLDA VI; WS Code M MA58
  • Conjugation: Un-conjugated